Embolic microspheres
US11235084B2 · kind B2 · utility
0Cited by
3References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2018 |
| Grant date | Feb 1, 2022 |
| Priority date | — |
| Expiry date | Jul 23, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M25/0097
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In some aspects, the disclosure pertains to injectable particles that contain at least one pH-altering agent that is configured to be released from the injectable particles in vivo, upon embolization of an intratumoral artery of a tumor with the injectable particles. In certain instances, the pH-altering agent may be a basic agent having a pH value of 7.5, a buffering agent having a pKa value of 7.6 or more, or both. Other aspects of the disclosure pertain to preloaded containers containing such injectable particles and methods of using such injectable particles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.